 |
Peginterferon alfa-2b
Product Approval Information - Licensing Action
Proper name: Peginterferon alfa-2b
Tradename: PEG-Intron
Manufacturer: Schering Corp, Kenilworth, NJ, License #0994
Indication for Use: Combination therapy with Ribavirin, USP (Rebetol), for the treatment of chronic hepatitis C
Approval Date: 8/7/2001
Type of submission: Biologics license application supplement
Approval Letter (PDF),
(Text)
Label
(PDF),
(Text)
Medication Guide (PDF)
Last Updated: 9/24/2001
 Back
to Top 
Back to Index
Updated: September 25, 2003 |
|
